DCM
JNP

Delpha Capital Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Delpha Capital Management’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed – – 1652
2017
Q4 		$0 Buy
+100
New +$486 ﹤0.01% 1688

Other funds holding JNP

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $9.05B AUM 13.04% 1-Year Est. Return
AG
Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Delpha Capital Management's JNP Position: Q1 2018 in Review

Delpha Capital Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q1 2018, closing a stake of 100 shares.

Delpha Capital Management first reported a position in JNP in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 47 funds tracked by Wall St. Rank hold JNP as of Q1 2018.

  • Delpha Capital Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 100 Juniper Pharmaceuticals, Inc. Common Stock shares in Q1 2018.
  • Delpha Capital Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $0 in Q4 2017.
  • 47 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.